318 related articles for article (PubMed ID: 10905482)
21. PDGF Facilitates Direct Lineage Reprogramming of Hepatocytes to Functional β-Like Cells Induced by Pdx1 and Ngn3.
Chang FP; Cho CH; Shen CR; Chien CY; Ting LW; Lee HS; Shen CN
Cell Transplant; 2016 Oct; 25(10):1893-1909. PubMed ID: 27076404
[TBL] [Abstract][Full Text] [Related]
22. Glucagon stimulates expression of the inducible cAMP early repressor and suppresses insulin gene expression in pancreatic beta-cells.
Hussain MA; Daniel PB; Habener JF
Diabetes; 2000 Oct; 49(10):1681-90. PubMed ID: 11016452
[TBL] [Abstract][Full Text] [Related]
23. B-cell translocation gene 2 positively regulates GLP-1-stimulated insulin secretion via induction of PDX-1 in pancreatic β-cells.
Hwang SL; Kwon O; Kim SG; Lee IK; Kim YD
Exp Mol Med; 2013 May; 45(5):e25. PubMed ID: 23703573
[TBL] [Abstract][Full Text] [Related]
24. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
Wang X; Zhou J; Doyle ME; Egan JM
Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
[TBL] [Abstract][Full Text] [Related]
25. Functional regions of the homeodomain protein IDX-1 required for transactivation of the rat somatostatin gene.
Lu M; Miller C; Habener JF
Endocrinology; 1996 Jul; 137(7):2959-67. PubMed ID: 8770920
[TBL] [Abstract][Full Text] [Related]
26. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
[TBL] [Abstract][Full Text] [Related]
27. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
[TBL] [Abstract][Full Text] [Related]
28. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels.
Gremlich S; Bonny C; Waeber G; Thorens B
J Biol Chem; 1997 Nov; 272(48):30261-9. PubMed ID: 9374511
[TBL] [Abstract][Full Text] [Related]
29. Hes3 is expressed in the adult pancreatic islet and regulates gene expression, cell growth, and insulin release.
Masjkur J; Arps-Forker C; Poser SW; Nikolakopoulou P; Toutouna L; Chenna R; Chavakis T; Chatzigeorgiou A; Chen LS; Dubrovska A; Choudhary P; Uphues I; Mark M; Bornstein SR; Androutsellis-Theotokis A
J Biol Chem; 2014 Dec; 289(51):35503-16. PubMed ID: 25371201
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the pdx1 gene promoter in pancreatic beta-cells.
Campbell SC; Macfarlane WM
Biochem Biophys Res Commun; 2002 Nov; 299(2):277-84. PubMed ID: 12437983
[TBL] [Abstract][Full Text] [Related]
31. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
Lam NT; Kieffer TJ
Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501
[TBL] [Abstract][Full Text] [Related]
32. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of the beneficial and protective effects of exenatide in diabetic rats.
Lotfy M; Singh J; Rashed H; Tariq S; Zilahi E; Adeghate E
J Endocrinol; 2014 Mar; 220(3):291-304. PubMed ID: 24353307
[TBL] [Abstract][Full Text] [Related]
34. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.
Farilla L; Hui H; Bertolotto C; Kang E; Bulotta A; Di Mario U; Perfetti R
Endocrinology; 2002 Nov; 143(11):4397-408. PubMed ID: 12399437
[TBL] [Abstract][Full Text] [Related]
35. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
Wang Q; Brubaker PL
Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459
[TBL] [Abstract][Full Text] [Related]
36. Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases.
Lee YS; Jun HS
Int J Med Sci; 2018; 15(6):603-609. PubMed ID: 29725251
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide-1 enhances production of insulin in insulin-producing cells derived from mouse embryonic stem cells.
Bai L; Meredith G; Tuch BE
J Endocrinol; 2005 Aug; 186(2):343-52. PubMed ID: 16079260
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
39. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.
Mojsov S; Weir GC; Habener JF
J Clin Invest; 1987 Feb; 79(2):616-9. PubMed ID: 3543057
[TBL] [Abstract][Full Text] [Related]
40. Evaluating insulin secretagogues in a humanized mouse model with functional human islets.
Luo J; Nguyen K; Chen M; Tran T; Hao J; Tian B; Rulifson IC; Zhang Y; Tian L; Zhang Y; Lopez E; Lin DC; Wang Y; Ma Z; Houze J; Guo Z
Metabolism; 2013 Jan; 62(1):90-9. PubMed ID: 22982177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
